Operating
Change in AP
Vertex Pharmaceuticals Change in AP increased by 208.5% to $38.30M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 356.0%, from $8.40M to $38.30M. Over 3 years (FY 2021 to FY 2025), Change in AP shows an upward trend with a 4.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalHigher is better
VolatilityVolatile
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
An increase suggests the company is successfully leveraging its scale to negotiate better payment terms with its supply chain.
Detailed definition
Accounts payable represents the change in the amount the company owes to its suppliers for materials or services purchas...
Peer comparison
Dominant market leaders often have high accounts payable as they can dictate longer payment terms to their vendors.
Metric ID:
cf_change_in_accounts_payableHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$13.70M | $2.30M | $53.94M | -$14.50M | $45.30M | -$69.90M | $159.90M | $35.70M | $35.60M | $9.20M | $100.00K | -$25.10M | $66.10M | $8.40M | $26.20M | $7.60M | -$35.30M | $38.30M |
| QoQ Change | — | +116.8% | >999% | -126.9% | +412.4% | -254.3% | +328.8% | -77.7% | -0.3% | -74.2% | -98.9% | <-999% | +363.3% | -87.3% | +211.9% | -71.0% | -564.5% | +208.5% |
| YoY Change | — | — | — | — | +430.6% | <-999% | +196.4% | +346.2% | -21.4% | +113.2% | -99.7% | -170.5% | +618.5% | — | >999% | +130.3% | -153.4% | +356.0% |
Range-$69.90M – $159.90M
CAGR+27.4%
Avg YoY Growth>999%
Median YoY Growth+130.3%
Change in AP at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's change in ap?
- Vertex Pharmaceuticals (VRTX) reported change in ap of $38.30M in Q4 2025.
- How has Vertex Pharmaceuticals's change in ap changed year-over-year?
- Vertex Pharmaceuticals's change in ap increased by 356.0% year-over-year, from $8.40M to $38.30M.
- What is the long-term trend for Vertex Pharmaceuticals's change in ap?
- Over 3 years (2021 to 2025), Vertex Pharmaceuticals's change in ap has grown at a 4.9% compound annual growth rate (CAGR), from $31.90M to $36.80M.
- What does change in ap mean?
- The change in the amount of money the company owes to its suppliers.